A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards,

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

A first-of-its-kind study testing an mRNA vaccine for norovirus, the highly contagious winter vomiting bug, is launching in the UK and around the world. Norovirus, which causes vomiting and diarrhoea, is usually the result of a viral or bacterial infection and typically peaks in the colder months.

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 hospital admissions in the UK every year

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative vaccine trial delivered through the government-funded National Institute for Health and Care Research.

A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the “burden on the NHS”, the Health Secretary has said. The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

A first-of-its-kind vaccine against the vomit bug norovirus is being trialled in the UK, using the same tech employed in the Covid jab. Thousands of Brits end up in hospital every year due to the highly contagious virus,